| 000 | 01710 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517020127.0 | ||
| 264 | 0 | _c20160106 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1748-1716 | ||
| 024 | 7 |
_a10.1111/apha.12474 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJean-Gilles, L | |
| 245 | 0 | 0 |
_aEffects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells. _h[electronic resource] |
| 260 |
_bActa physiologica (Oxford, England) _cMay 2015 |
||
| 300 |
_a63-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-1beta _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-6 _xpharmacology |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _ximmunology |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xgenetics |
| 650 | 0 | 4 |
_aReceptor, Cannabinoid, CB2 _xgenetics |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBraitch, M | |
| 700 | 1 | _aLatif, M L | |
| 700 | 1 | _aAram, J | |
| 700 | 1 | _aFahey, A J | |
| 700 | 1 | _aEdwards, L J | |
| 700 | 1 | _aRobins, R A | |
| 700 | 1 | _aTanasescu, R | |
| 700 | 1 | _aTighe, P J | |
| 700 | 1 | _aGran, B | |
| 700 | 1 | _aShowe, L C | |
| 700 | 1 | _aAlexander, S P | |
| 700 | 1 | _aChapman, V | |
| 700 | 1 | _aKendall, D A | |
| 700 | 1 | _aConstantinescu, C S | |
| 773 | 0 |
_tActa physiologica (Oxford, England) _gvol. 214 _gno. 1 _gp. 63-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apha.12474 _zAvailable from publisher's website |
| 999 |
_c24644859 _d24644859 |
||